Emma Marshman
Impact in
- Oncology top 10%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
Papers in
-
- Cancer, Lipids, and Metabolism 2
- Co-authors
- Christopher S. PottenCatherine BoothCharles StreuliAlastair J.M. WatsonPenelope D. OttewellMelissa WestwoodMartin GibsonKirk Siddals
- Journals
- Journal of Biological Chemistry (2 papers)The Journal of Pathology (2 papers)British Journal of Cancer (1 paper)Alimentary Pharmacology & Therapeutics (1 paper)BioEssays (1 paper)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Emma Marshman
14 papers receiving 935 citations
Peers
Comparison fields: 5 of 88
- Oncology 353
- Cancer Research 126
- Endocrinology, Diabetes and Metabolism 138
- Molecular Biology 506
- Immunology and Allergy 38
Countries citing papers authored by Emma Marshman
This map shows the geographic impact of Emma Marshman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Marshman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Marshman more than expected).
Fields of papers citing papers by Emma Marshman
This network shows the impact of papers produced by Emma Marshman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Marshman. The network helps show where Emma Marshman may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Emma Marshman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 32 | |
| 2 | 2004 | 62 | |
| 3 | 2004 | 11 | |
| 4 | 2003 | 72 | |
| 5 | 2002 | 71 | |
| 6 | 2002 | 445 | |
| 7 | 2002 | 70 | |
| 8 | 2001 | 10 | |
| 9 | 2001 | 125 | |
| 10 | 2001 | 10 | |
| 11 | 2001 | 12 | |
| 12 | 2000 | 24 | |
| 13 | Prevention of thymidine and hypoxanthine rescue from MTA (LY231514) growth inhibition by dipyridamole in human lung cancer cell lines. | 1999 | 14 |
| 14 | Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro. | 1998 | 5 |
About Emma Marshman
Emma Marshman is a scholar working on Physiology, Cancer Research, Oncology, Endocrinology, Diabetes and Metabolism and Immunology and Allergy, having authored 14 papers that have together received 963 indexed citations. Recurring topics across this work include Biochemical and Molecular Research (3 papers), Metabolism, Diabetes, and Cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Cancer Cells and Metastasis (2 papers), Cell death mechanisms and regulation (2 papers), FOXO transcription factor regulation (2 papers), Growth Hormone and Insulin-like Growth Factors (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Oncology (353 citations), Cancer Research (126 citations), Endocrinology, Diabetes and Metabolism (138 citations), Molecular Biology (506 citations) and Immunology and Allergy (38 citations). Emma Marshman has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Christopher S. Potten, Catherine Booth, Charles Streuli, Alastair J.M. Watson, Penelope D. Ottewell, Melissa Westwood, Martin Gibson, Kirk Siddals, David J. Flint and David R. Newell. Their work appears in journals such as Journal of Biological Chemistry, The Journal of Pathology, British Journal of Cancer, Alimentary Pharmacology & Therapeutics and BioEssays.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.